Richard Larson, MD Receives the American Society of Hematology’s Stratton Medal
Richard Larson,MD , Professor of Medicine (Hematology/Oncology) and Director of the the Hematologic Malignancy Program has been named as the recipient of the American Society of Hematology’s (ASH) 2019 Henry M. Stratton Medal for his seminal contributions to clinical hematology research. Dr. Larson’s career has been dedicated to the design and leadership of groundbreaking therapeutic trials for patients with leukemia, and he has made significant strides in understanding the genetic basis of leukemia and translating these insights into more effective treatments for patients. Dr. Larson led the Leukemia Committee of the Cancer and Leukemia Group B (CALGB), now called the … Read More